Stoke Therapeutics Inc. and Biogen Inc. said Tuesday they are entering a collaboration to develop and commercialize a ...

Biogen Inc. has agreed to pay as much as $550 million to develop and sell a drug to treat a genetic seizure disorder, the ...

In exchange for $165 million, Biogen now has access to zorevunersen, a potential first-of-its-kind treatment for Dravet ...

Southern Methodist University biology researchers are uncovering how brain, heart, and lung connections may hold the key to ...

Hundreds of children in England with a rare and severe form of epilepsy are set to benefit from a new drug being rolled out ...

New life-changing treatment option fenfluramine recommended for type of rare epilepsy, Lennox–Gastaut syndrome ...

Hundreds of children with severe epilepsy will be able to benefit from a groundbreaking ... for those who can’t tolerate existing cannabis-based treatment and the fast-tracking of this treatment to be ...

New research focuses on diagnostic delays experienced by people with epilepsy, a neurological disorder characterized by unpredictable seizures that affects over 3 million people in the United States ...

Any patient suffering from new or worsening medical symptoms hopes for a relatively quick and accurate diagnosis.

Feb. 19, 2025 — New research focuses on diagnostic delays experienced by people with epilepsy, a neurological disorder characterized by unpredictable seizures that affects over 3 million people ...

CeriBell's AI-powered EEG system offers rapid seizure diagnosis. The stock is undervalued by at least 50% over the long-term, ...